1. Stocks
  2. Astec Lifesciences Ltd.
  3. Swot
swot-logo

Astec Lifesciences Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Astec Lifesciences Ltd. has 5 Strengths, 19 Weaknesses, 1 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Positive Breakout First Resistance ( LTP > R1)

PEG lower than Industry PEG

Company with Zero Promoter Pledge

Stock with Low PE (PE < = 10)

Top Gainers

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score

Low DVM Stocks - Stocks to Exercise Caution On

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Risky Value (DVM)

Low durability companies

Performance of Stocks with Low Trendlyne Durability Score versus Benchmarks

Inefficient use of capital to generate profits - RoCE declining in the last 2 years

Inefficient use of shareholder funds - ROE declining in the last 2 years

Inefficient use of assets to generate profits - ROA declining in the last 2 years

Degrowth in Revenue and Profit

Low Piotroski Score : Companies with weak financials

Annual net profit declining for last 2 years

Weak Momentum: Price below Short, Medium and Long Term Averages

Companies Increasing Debt as per Annual Report

RSI indicating price weakness

Highest fall from 52 Week High

Near 52 Week Low

Declining profitability: Falling ROCE

Stocks Underperforming their Industry Price Change in the Quarter

FII / FPI or Institutions increasing their shareholding

Rising Delivery Percentage Compared to Prev Day

Decline in Net Profit with falling Profit Margin (QoQ)

Decline in Quarterly Net Profit with falling Profit Margin (YoY)